CHI3L1 and inflammatory bowel disease: Recent studies suggest that Chi3l1 is a novel neutrophil autoantigenic target in IBD, whereas IgA and secretory IgA (sIgA) to Chi3l1 may facilitate the serological diagnosis of IBD [99,100].